Atanasio Pandiella

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Positive Breast Cancer

Top Venues

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Sheila Almaraz-Postigo, Eduardo Sanz, Atanasio Pandiella, Elena Díaz-Rodríguez
Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer. Nutrients 16 (15) (2024)
Sheila Almaraz-Postigo, Eduardo Sanz, Atanasio Pandiella, Elena Díaz-Rodríguez
Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer. Nutrients 16 (15) (2024)
Yolanda María Guillén-Pérez, María Jesús Ortiz-Ruiz, Javier Márquez, Atanasio Pandiella, Azucena Esparís-Ogando
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression. International journal of molecular sciences 25 (6) (2024)
Inés Romero-Pérez, Elena Díaz-Rodríguez, Laura Sánchez-Díaz, Juan Carlos Montero, Atanasio Pandiella
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer. Oncogenesis 13 (1) (2024)
Inés Romero-Pérez, Elena Díaz-Rodríguez, Laura Sánchez-Díaz, Juan Carlos Montero, Atanasio Pandiella
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer. Oncogenesis 13 (1) (2024)
Yolanda María Guillén-Pérez, María Jesús Ortiz-Ruiz, Javier Márquez, Atanasio Pandiella, Azucena Esparís-Ogando
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression. International journal of molecular sciences 25 (6) (2024)
Inés Romero-Pérez, Elena Díaz-Rodríguez, Laura Sánchez-Díaz, Juan Carlos Montero, Atanasio Pandiella
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer. Oncogenesis 13 (1) (2024)
Yolanda María Guillén-Pérez, María Jesús Ortiz-Ruiz, Javier Márquez, Atanasio Pandiella, Azucena Esparís-Ogando
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression. International journal of molecular sciences 25 (6) (2024)
Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Juan Carlos Montero, Sofía Del Carmen, Mar Abad, Sara García-Alonso, Somshuvra Bhattacharya, Kristin Calar, Pilar de la Puente, Alberto Ocaña, Atanasio Pandiella, Azucena Esparís-Ogando
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and translational medicine 13 (4) (2023)
Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez, Enrique J Arenas Lahuerta, Cristina Bernadó Bernadó Morales, Beatriz Morancho, Marta Escorihuela, Sandra Pérez-Ramos, Santiago Escriva-de-Romani, Lucía Gandullo-Sánchez, Atanasio Pandiella, Anna Esteve-Codina, Veronica Rodilla, Fred A Dijcks, Wim H A Dokter, Javier Cortes, Cristina Saura, Joaquín Arribas
Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer. Cancer research (2022)
Lucía Gandullo-Sánchez, Alberto Ocaña, Atanasio Pandiella
HER3 in cancer: from the bench to the bedside. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Juan Carlos Montero, Atanasio Pandiella
PDCD4 limits prooncogenic neuregulin-ErbB signaling. Cellular and molecular life sciences : CMLS 78 (4) (2020)
Lucía Gandullo-Sánchez, Emily Capone, Alberto Ocaña, Stefano Iacobelli, Gianluca Sala, Atanasio Pandiella
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies. EMBO molecular medicine 12 (5) (2020)